These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 27579999)

  • 1. Effects of the GLP-1 Agonist Exendin-4 on Intravenous Ethanol Self-Administration in Mice.
    Sørensen G; Caine SB; Thomsen M
    Alcohol Clin Exp Res; 2016 Oct; 40(10):2247-2252. PubMed ID: 27579999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex-dependent divergence in the effects of GLP-1 agonist exendin-4 on alcohol reinforcement and reinstatement in C57BL/6J mice.
    Díaz-Megido C; Thomsen M
    Psychopharmacology (Berl); 2023 Jun; 240(6):1287-1298. PubMed ID: 37106129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The glucagon-like peptide 1 analogue Exendin-4 attenuates alcohol mediated behaviors in rodents.
    Egecioglu E; Steensland P; Fredriksson I; Feltmann K; Engel JA; Jerlhag E
    Psychoneuroendocrinology; 2013 Aug; 38(8):1259-70. PubMed ID: 23219472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucagon-like peptide-1 receptors in nucleus accumbens, ventral hippocampus, and lateral septum reduce alcohol reinforcement in mice.
    Allingbjerg ML; Hansen SN; Secher A; Thomsen M
    Exp Clin Psychopharmacol; 2023 Jun; 31(3):612-620. PubMed ID: 36480394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain Site-Specific Inhibitory Effects of the GLP-1 Analogue Exendin-4 on Alcohol Intake and Operant Responding for Palatable Food.
    Colvin KJ; Killen HS; Kanter MJ; Halperin MC; Engel L; Currie PJ
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33352692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucagon-like peptide-1 receptors within the nucleus of the solitary tract regulate alcohol-mediated behaviors in rodents.
    Vallöf D; Vestlund J; Jerlhag E
    Neuropharmacology; 2019 May; 149():124-132. PubMed ID: 30772374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The glucagon-like peptide 1 receptor agonist Exendin-4 decreases relapse-like drinking in socially housed mice.
    Thomsen M; Dencker D; Wörtwein G; Weikop P; Egecioglu E; Jerlhag E; Fink-Jensen A; Molander A
    Pharmacol Biochem Behav; 2017 Sep; 160():14-20. PubMed ID: 28778739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain region specific glucagon-like peptide-1 receptors regulate alcohol-induced behaviors in rodents.
    Vallöf D; Kalafateli AL; Jerlhag E
    Psychoneuroendocrinology; 2019 May; 103():284-295. PubMed ID: 30771711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of lateral septum glucagon-like peptide 1 receptors in food intake.
    Terrill SJ; Jackson CM; Greene HE; Lilly N; Maske CB; Vallejo S; Williams DL
    Am J Physiol Regul Integr Comp Physiol; 2016 Jul; 311(1):R124-32. PubMed ID: 27194565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral and central GLP-1 receptor populations mediate the anorectic effects of peripherally administered GLP-1 receptor agonists, liraglutide and exendin-4.
    Kanoski SE; Fortin SM; Arnold M; Grill HJ; Hayes MR
    Endocrinology; 2011 Aug; 152(8):3103-12. PubMed ID: 21693680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucagon-Like Peptide-1 Receptor Activation in the Ventral Tegmental Area Decreases the Reinforcing Efficacy of Cocaine.
    Schmidt HD; Mietlicki-Baase EG; Ige KY; Maurer JJ; Reiner DJ; Zimmer DJ; Van Nest DS; Guercio LA; Wimmer ME; Olivos DR; De Jonghe BC; Hayes MR
    Neuropsychopharmacology; 2016 Jun; 41(7):1917-28. PubMed ID: 26675243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucagon-Like Peptide-1 Receptor Agonist Treatment Does Not Reduce Abuse-Related Effects of Opioid Drugs.
    Bornebusch AB; Fink-Jensen A; Wörtwein G; Seeley RJ; Thomsen M
    eNeuro; 2019; 6(2):. PubMed ID: 31058214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alcohol-mediated behaviours and the gut-brain axis; with focus on glucagon-like peptide-1.
    Jerlhag E
    Brain Res; 2020 Jan; 1727():146562. PubMed ID: 31759971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral operant ethanol self-administration in the absence of explicit cues, food restriction, water restriction and ethanol fading in C57BL/6J mice.
    Stafford AM; Anderson SM; Shelton KL; Brunzell DH
    Psychopharmacology (Berl); 2015 Oct; 232(20):3783-95. PubMed ID: 26268145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of glucagon-like peptide 1 analogs on alcohol intake in alcohol-preferring vervet monkeys.
    Thomsen M; Holst JJ; Molander A; Linnet K; Ptito M; Fink-Jensen A
    Psychopharmacology (Berl); 2019 Feb; 236(2):603-611. PubMed ID: 30382353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased operant responding for ethanol in male C57BL/6J mice: specific regulation by the ERK1/2, but not JNK, MAP kinase pathway.
    Faccidomo S; Besheer J; Stanford PC; Hodge CW
    Psychopharmacology (Berl); 2009 May; 204(1):135-47. PubMed ID: 19125235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucagon-like peptide-1 receptor agonists suppress water intake independent of effects on food intake.
    McKay NJ; Kanoski SE; Hayes MR; Daniels D
    Am J Physiol Regul Integr Comp Physiol; 2011 Dec; 301(6):R1755-64. PubMed ID: 21975647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of nausea in food intake and body weight suppression by peripheral GLP-1 receptor agonists, exendin-4 and liraglutide.
    Kanoski SE; Rupprecht LE; Fortin SM; De Jonghe BC; Hayes MR
    Neuropharmacology; 2012 Apr; 62(5-6):1916-27. PubMed ID: 22227019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxytocin Reduces Ethanol Self-Administration in Mice.
    King CE; Griffin WC; Luderman LN; Kates MM; McGinty JF; Becker HC
    Alcohol Clin Exp Res; 2017 May; 41(5):955-964. PubMed ID: 28212464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of glucagon-like peptide-1 receptor stimulation and blockade on food consumption and body weight in rats treated with a cannabinoid CB1 receptor agonist WIN 55,212-2.
    Radziszewska E; Bojanowska E
    Med Sci Monit Basic Res; 2013 Jan; 19():6-11. PubMed ID: 23291632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.